Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Livestock Dewormers Market

Livestock Dewormers Market Trends

Report ID: GMI12670
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Livestock Dewormers Market Trends

The increasing livestock population is a significant driver of the market, as it directly influences the demand for effective parasite management solutions.

With the growing global demand for meat, milk, and other animal-derived products, farmers are expanding livestock herds to meet these needs.
For instance, as per the Food and Agriculture Organization (FAO), the global cattle population reached 1.5 billion in 2021, a 1.4% increase from the previous year.
A larger livestock population elevates the risk of parasitic infestations, which can impact animal health, productivity, and overall economic returns.
Consequently, this drives the adoption of dewormers as an essential component of livestock management.
Moreover, government initiatives promoting animal healthcare and productivity further amplify the demand for deworming products, ensuring optimal growth rates and reducing disease-related losses in livestock.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global livestock dewormers industry was valued at USD 7.9 billion in 2024 and is projected to grow at a CAGR of 4.8% from 2025 to 2034, driven by increasing demand for animal protein and dairy products worldwide.

The cattle segment accounted for USD 3.6 billion in 2024, dominating the market due to their critical role in global agriculture and dairy industries.

The U.S. livestock dewormers market was valued at USD 3.1 billion in 2024, supported by the agricultural sector's focus on livestock health and the prevalence of parasitic infections in animals like cattle, poultry, and swine.

Key players in the market include Boehringer Ingelheim, Bimeda, Ceva Sante Animale, Durvet, Elanco Animal Health, First Priority, Intas Pharmaceuticals, Jeffers, Manna Pro Products, Merck Animal Health, Phibro Animal Health, and Virbac.